Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Yang

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Circulation|September 11, 2013
Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy studyEloi Marijon, Jean-Yves Le Heuzey, Stuart Connolly, et al.
Genome Biology and Evolution|May 8, 2014
Comparative genomic analysis of malaria mosquito vector-associated novel pathogen Elizabethkingia anophelisJeanette Teo, Sean Yang-Yi Tan, Yang Liu, et al.
The American Journal of Cardiology|December 24, 2013
Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)Paolo Verdecchia, Gianpaolo Reboldi, Giuseppe Di Pasquale, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Histone H3 tail charge patterns govern nucleosome condensate formation and dynamicsErin F Hammonds, Anurag Singh, Krishna K Suresh, et al.
Nucleic Acids Research|February 9, 2026
Histone H3 tail charge patterns govern nucleosome condensate formation and dynamicsErin F Hammonds, Anurag Singh, Krishna K Suresh, et al.
Circulation|December 29, 2012
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trialAntonio L Dans, Stuart J Connolly, Lars Wallentin, et al.
Circulation|October 3, 2012
Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trialHarriette G C Van Spall, Lars Wallentin, Salim Yusuf, et al.
Circulation|May 7, 2013
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”Jeff S Healey, John Eikelboom, Sean Yang, et al.
Annals of Internal Medicine|November 16, 2011
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trialJonas Oldgren, Marco Alings, Harald Darius, et al.
Circulation|December 15, 2010
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillationMichael D Ezekowitz, Lars Wallentin, Stuart J Connolly, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Circulation|September 11, 2013
Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy studyEloi Marijon, Jean-Yves Le Heuzey, Stuart Connolly, et al.
Genome Biology and Evolution|May 8, 2014
Comparative genomic analysis of malaria mosquito vector-associated novel pathogen Elizabethkingia anophelisJeanette Teo, Sean Yang-Yi Tan, Yang Liu, et al.
The American Journal of Cardiology|December 24, 2013
Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)Paolo Verdecchia, Gianpaolo Reboldi, Giuseppe Di Pasquale, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Histone H3 tail charge patterns govern nucleosome condensate formation and dynamicsErin F Hammonds, Anurag Singh, Krishna K Suresh, et al.
Nucleic Acids Research|February 9, 2026
Histone H3 tail charge patterns govern nucleosome condensate formation and dynamicsErin F Hammonds, Anurag Singh, Krishna K Suresh, et al.
Circulation|December 29, 2012
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trialAntonio L Dans, Stuart J Connolly, Lars Wallentin, et al.
Circulation|October 3, 2012
Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trialHarriette G C Van Spall, Lars Wallentin, Salim Yusuf, et al.
Circulation|May 7, 2013
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”Jeff S Healey, John Eikelboom, Sean Yang, et al.
Annals of Internal Medicine|November 16, 2011
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trialJonas Oldgren, Marco Alings, Harald Darius, et al.
Circulation|December 15, 2010
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillationMichael D Ezekowitz, Lars Wallentin, Stuart J Connolly, et al.
Pageof 5